Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Nanosci Nanotechnol ; 13(12): 8229-38, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24266218

ABSTRACT

Gold nanoparticles were green-synthesized using a glycosaminoglycan, chondroitin sulfate, as the reducing agent by mixing Au3+ and chondroitin sulfate under heating. Chondroitin sulfate-reduced gold nanoparticles were characterized by UV-Vis spectrophotometry, high resolution transmission electron microscopy and atomic force microscopy. The yield of Au3+ to Au0 was measured as 80.1% by inductively coupled plasma-atomic emission spectroscopy. A mostly spherical shape, with an average diameter of 44.68 +/- 11.25 nm, was observed from the atomic force microscopy images. Using chondroitin sulfate-reduced gold nanoparticles, we developed a melamine nanosensor that provides a simplified method to detect melamine in infant formula. With an increase in the melamine concentration in the gold nanoparticle solution, the characteristic surface plasmon resonance band of gold nanoparticles at 530 nm decreased, whereas a new peak appeared at 620 nm. There was a linear relationship between the absorbance ratio (A620/A530) and the melamine concentration in the range of 0.1-10 microM. The practical use of the proposed method was verified by quantifying melamine spiked in real infant formula at concentrations as low as 12.6 ppb. The nanosensing of melamine using chondroitin sulfate-reduced gold nanoparticles can be a promising technique for quick on-site melamine screening of milk products.


Subject(s)
Chondroitin Sulfates/chemistry , Gold/chemistry , Metal Nanoparticles/chemistry , Triazines/analysis , Humans , Infant , Infant Food/analysis , Limit of Detection , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Oxidation-Reduction , Spectrophotometry, Ultraviolet , Surface Plasmon Resonance
2.
J Nanosci Nanotechnol ; 13(8): 5787-93, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23882836

ABSTRACT

We report the synthesis of biogenic silver nanoparticles using chlorogenic acid as a bioreducing agent. Chlorogenic acid is a polyphenol compound abundant in coffee. UV-Vis spectra showed the characteristic surface plasmon resonance band at 415 nm, indicating the successful synthesis of biogenic silver nanoparticles. Spherical and irregular shaped nanoparticles were observed with an average diameter of 19.29 +/- 8.23 nm. The reaction yield from silver ion to silver nanoparticles was observed as 95.43% by using inductively coupled plasma-mass spectrometry. Fourier transform infrared spectra revealed that the -C = O groups of chlorogenic acid may coordinate or complex into silver nanoparticles. Biogenic silver nanoparticles exerted higher antibacterial activity against Gram-negative bacteria than against Gram-positive bacteria. Interestingly, a comparable antibacterial activity to a standard antibiotic was observed against two strains of Pseudomonas aeruginosa (minimum inhibitory concentration of 0.66 microg/mL). The synergistic effect of a combination of silver nanoparticles and chlorogenic acid on antibacterial activity is obvious, leading to approximately 8-fold enhancement in the case of Pseudomonas aeruginosa when compared with chlorogenic acid alone. The present report suggests that a pure compound with a plant origin is capable of being a bioreducing agent for the synthesis of biogenic silver nanoparticles with superior antibacterial activity, opening up many applications in nanomedicine and nanobiotechnology.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chlorogenic Acid/chemistry , Metal Nanoparticles/chemistry , Silver/chemistry , Anti-Bacterial Agents/chemistry , Carbon/chemistry , Mass Spectrometry , Microbial Sensitivity Tests , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Nanomedicine/methods , Nanotechnology/methods , Oxygen/chemistry , Particle Size , Pseudomonas aeruginosa/drug effects , Reducing Agents/pharmacology , Spectrophotometry, Ultraviolet , Spectroscopy, Fourier Transform Infrared
3.
J Nanosci Nanotechnol ; 12(9): 7087-95, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23035437

ABSTRACT

We report a green synthesis of silver nanoparticles that uses extracts from the aerial part of Artemisia capillaris. Both water and 70% ethanol extracts successfully generated silver nanoparticles. The formation of silver nanoparticles was confirmed by surface plasmon resonance bands, Fourier transform-infrared spectra, high resolution-transmission electron and atomic force microscopic images. Various shapes of silver nanoparticles were generated with an average diameter of 29.71 nm with water extract and 29.62 nm with 70% ethanol extract. An improvement in antibacterial activity (MIC 8.35-16.7 microg/mL) was observed against a total of twenty different strains of Gram-negative and Gram-positive bacteria. A remarkable enhancement (approximately 12-fold) was observed against Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Klebsiella oxytoca, and Klebsiella areogenes when compared with the extract alone. Silver nanoparticles produced by the 70% ethanol extract showed slightly higher antibacterial activity than those generated with the water extract. The correlation between total flavonoid content of each extract and the antibacterial activity did not exert any significant relationships. This report suggests that plant extracts have the potential to be used as powerful reducing agents for the production of biocompatible silver nanoparticles possessing enhanced antibacterial activities.


Subject(s)
Anti-Bacterial Agents/pharmacology , Artemisia/chemistry , Nanoparticles/chemistry , Plant Extracts/pharmacology , Silver/chemistry , Anti-Bacterial Agents/chemistry , Flavonoids/analysis , Microscopy, Atomic Force , Microscopy, Electron, Transmission
4.
J Nanosci Nanotechnol ; 12(5): 3884-95, 2012 May.
Article in English | MEDLINE | ID: mdl-22852321

ABSTRACT

The resistance to current antibiotics results in the emergence of health-threatening bacteria. Silver nanoparticles are known to exhibit broad-spectrum antibacterial activities without the development of resistance. Herein, we developed a green synthetic method for the preparation of silver nanoparticles with sialyllactose instead of toxic chemicals as a reducing agent, which would improve its therapeutic applicability and increase its biocompatibility. Oven incubation, autoclaving and microwave irradiation methods were applied to prepare the silver nanoparticles. High resolution-transmission electron microscopy and atomic force microscopy images revealed mostly spherical and amorphous silver nanoparticles with an average diameter of 23.64 nm. Fourier Transform-infrared spectra suggest that the N-H amide of sialyllactose might be involved in the binding of silver nanoparticles. Based on thermogravimetric analyses, 2,3-sialyllactose-reduced silver nanoparticles are composed of 54.3 wt% organic components and 45.7 wt% metallic silver. Enhanced antibacterial activities of silver nanoparticles (approximately 8-fold) were observed against Pseudomonas aeruginosa, Escherichia coli and Salmonella typhimurium (minimum inhibitory concentration 16 microg/mL). Next, we employed the use of carbohydrate stabilizers to increase the stability of silver nanoparticles during a freeze-drying process. It was found that sucrose and trehalose were the most effective stabilizers. In addition, silver nanoparticles possessed excellent salt stability as well as on-the-shelf stability in the presence of these stabilizers. Derivatives of sialic acid are known to be anti-influenza agents; therefore, the newly prepared silver nanoparticles may serve as useful antibacterial and antiviral agents to cope with both pathogenic bacteria and viruses in the near future.


Subject(s)
Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Lactose/analogs & derivatives , Metal Nanoparticles/chemistry , Silver/chemistry , Sucrose/chemistry , Trehalose/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Carbohydrate Sequence , Drug Stability , Escherichia coli/drug effects , Excipients/chemistry , Freeze Drying/methods , Lactose/chemistry , Molecular Sequence Data , Pseudomonas aeruginosa/drug effects , Salmonella typhimurium/drug effects , Sialic Acids/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL